0001017491-14-000007.txt : 20140106 0001017491-14-000007.hdr.sgml : 20140106 20140106190726 ACCESSION NUMBER: 0001017491-14-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140102 FILED AS OF DATE: 20140106 DATE AS OF CHANGE: 20140106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APRICUS BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001017491 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870449967 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 222-8041 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STREET 2: SUITE 300 CITY: SAN DIEGO, STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: NEXMED INC DATE OF NAME CHANGE: 19970311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oppenheim Leonard A CENTRAL INDEX KEY: 0001307647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22245 FILM NUMBER: 14511569 MAIL ADDRESS: STREET 1: C/O NEXMED, INC. STREET 2: 350 CORPORATE BLVD CITY: ROBBINSVILLE STATE: NJ ZIP: 08691 4 1 wf-form4_138905323506565.xml FORM 4 X0306 4 2014-01-02 0 0001017491 APRICUS BIOSCIENCES, INC. APRI 0001307647 Oppenheim Leonard A 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2014-01-03 4 S 0 15212 2.4933 D 20449 D Stock Option (right to buy) 2.59 2014-01-02 4 A 0 16000 0 A 2024-01-02 Common Stock 16000.0 16000 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.48 to $2.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Includes 1,667 shares beneficially owned by the Reporting Person not previously reported that were identified upon review of the Issuer's records. The options to purchase shares of common stock were issued to the Reporting Person, a non-employee director of the Issuer, as an annual stock option grant for his service as a director of the Issuer. The options shall vest with respect to 1/12th of the underlying shares monthly, commencing with the first monthly vesting date of February 2, 2014, so that such options are fully vested on January 2, 2015. /s/ Steve Martin by power of attorney for Leonard A. Oppenheim, Esq. 2014-01-06 EX-24 2 oppenheimpowerofattorney11.htm OPPENHEIM POWER OF ATTORNEY OppenheimPowerofAttorney112014


POWER OF ATTORNEY
I hereby constitute and appoint each of Richard W. Pascoe and Steve Martin as my true and lawful attorney-in-fact to:
(1)    execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Apricus Biosciences, Inc. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Act”), and the rules thereunder;

(2)    do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)    take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each of the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all the acts such attorney-in-fact shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that each of the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Act.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date set forth below.


                        
By:

/s/ Leonard A. Oppenheim_

Print Name:

Leonard A. Oppenheim, Esq.
 
 
Date:
January 1, 2014